English  |  正體中文  |  简体中文  |  總筆數 :2856565  
造訪人次 :  53421892    線上人數 :  685
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yang c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 651-660 / 1273 (共128頁)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-08-13T06:33:57Z Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma Yen R.-F.; Huang C.-T.; Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Jin-Yuan Shih;Yang C.-H.;Yang P.-C.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; JIN-YUAN SHIH; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:54Z Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏 2020-08-13T06:33:53Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:53Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J.
臺大學術典藏 2020-08-13T06:33:53Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:52Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Chang Y.-C.; Yang C.-H.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:51Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed JIN-YUAN SHIH; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Chang Y.-L.; Chen C.-Y.; Chen C.-Y.;Chang Y.-L.;Jin-Yuan Shih;Lin J.-W.;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.
臺大學術典藏 2020-08-13T06:33:50Z Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment Chung K.-P.;Huang Y.-T.;Chang Y.-L.;Yu C.-J.;Yang C.-H.;Chang Y.-C.;Jin-Yuan Shih;Yang P.-C.; Chung K.-P.; Huang Y.-T.; Chang Y.-L.; Yu C.-J.; Yang C.-H.; Chang Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:50Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Tsai M.-F.; Yu C.-J.; Chen Y.-H.; JIN-YUAN SHIH; Chang Y.-L.; Kuo Y.-W.; Wu S.-G.; Wu S.-G.;Kuo Y.-W.;Chang Y.-L.;Jin-Yuan Shih;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-08-13T06:33:50Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.

顯示項目 651-660 / 1273 (共128頁)
<< < 61 62 63 64 65 66 67 68 69 70 > >>
每頁顯示[10|25|50]項目